Primary Bioscience, Inc. — Form D/A
Primary Bioscience, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2025-10-24. The offering totals $1.3M, of which $1.1M was reported sold. Industry: Other Technology.
Offering
- Filed: 2025-10-24
- Form: D/A
- Accession: 0002012695-25-000006
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $1.1M
- Remaining: $200K
- Investors: 2
- Date of first sale: 2025-10-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-560014
Issuer
- Name: Primary Bioscience, Inc.
- CIK: 0002012695
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2023
- Address: 7335 14TH AVE NW, SEATTLE, WA, 98117
- Phone: 414-293-2303
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Stacy Anderson | Director | Seattle, WA |
| Stacy Anderson | Executive Officer | Seattle, WA |
| Stacy Anderson | Promoter | Seattle, WA |
| Stacy Anderson | Related Person | Seattle, WA |
Other filings by this issuer (2)
More